Foxp3 expression in T regulatory cells and other cell lineages Christel DevaudPhillip K. DarcyMichael H. Kershaw Review 26 July 2014 Pages: 869 - 876
Generation and characterization of a novel human IgG1 antibody against vascular endothelial growth factor receptor 2 Wei XieDaojuan LiMin Wang Original Article 04 June 2014 Pages: 877 - 888
Bioactive compounds or metabolites from black raspberries modulate T lymphocyte proliferation, myeloid cell differentiation and Jak/STAT signaling Thomas A. MaceSamantha A. KingGregory B. Lesinski Original Article 04 June 2014 Pages: 889 - 900
Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy Francesca PrettoGiuliano EliaDario Neri Original Article 04 June 2014 Pages: 901 - 910
Intrinsically de-sialylated CD103+ CD8 T cells mediate beneficial anti-glioma immune responses Emmanuel JouanneauKeith L. BlackChristopher J. Wheeler Original Article 04 June 2014 Pages: 911 - 924
The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity Kea MartinPhilipp MüllerAlfred Zippelius Original Article 07 June 2014 Pages: 925 - 938
Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer Moon Jae ChungJeong Youp ParkSi Young Song Original Article 12 June 2014 Pages: 939 - 946
The anti-lymphoma activities of anti-CD137 monoclonal antibodies are enhanced in FcγRIII−/− mice Michelle A. SallinXiaoyu ZhangScott E. Strome Original Article 14 June 2014 Pages: 947 - 958
Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula Sandra Van LintSofie WilgenhofKris Thielemans Focussed Research Review 31 May 2014 Pages: 959 - 967
Engineered T cells for cancer therapy Carl H. JuneMarcela V. MausDavid L. Porter Focussed Research Review 19 June 2014 Pages: 969 - 975
Myeloid-derived suppressor cells and their role in CTLA-4 blockade therapy Yago Pico de CoañaGiuseppe MasucciRolf Kiessling Focussed Research Review 26 June 2014 Pages: 977 - 983
“Immunotherapy of cancer: present status and future promise”: Danish Cancer Society Symposium, Copenhagen, Denmark, 23rd–25th September 2013 Marco DoniaRikke LyngaaSine Reker Hadrup Meeting Report Open access 24 July 2014 Pages: 985 - 989